Kidney outcome after mild to moderate COVID-19.

Christian Schmidt-LauberSonja HänzelmannStefan SchunkElina Larissa PetersenAmmar AlabdoMaja LindenmeyerFabian HausmannPiotr KutaThomas RennéRaphael TwerenboldTanja ZellerStefan BlankenbergDanilo FliserTobias B Huber

Published in: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association (2023)

While mean eGFR was slightly lower in subjects after non-severe COVID-19, there was no evidence for an ongoing or progressive kidney sequela.

Keyphrases

coronavirus disease
sars cov
small cell lung cancer
multiple sclerosis
epidermal growth factor receptor
tyrosine kinase